Successful treatment of progressive macular hypomelanosis

  • Nicholas Leonard University of Massachusetts Medical School, Department of Dermatology, United States.
  • Steven Krueger University of Massachusetts Medical School, Department of Dermatology, United States.
  • Mehdi Rashighi | mehdi.rashighi@umassmed.edu University of Massachusetts Medical School, Department of Dermatology; Vitiligo Clinic and Research Center, University of Massachusetts Medical School, Worcester, United States.

Abstract

Progressive Macular Hypomelanosis (PMH) is a common but often misdiagnosed disorder of acquired hypopigmentation. An adolescent female presented with irregular, hypopigmented patches ultimately diagnosed as PMH. Complete repigmentation was achieved with narrowband UVB phototherapy, benzoyl peroxide wash, and clindamycin lotion.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

References

1. Relyveld GN, Menke HE, Westerhof W. Progressive macular hypomelanosis. Am J Clin Dermatol 2007;8:13–9.
https://www.ncbi.nlm.nih.gov/pubmed/17298102

2. Wang K, Nassef Y, Sahu J, et al. Facial involvement in progressive macular hypomelanosis. Cutis 2018;101:297–300.
https://mdedge-files-live.s3.us-east-2.amazonaws.com/files/s3fs-public/Document/April-2018/CT101004297.PDF

3. Shen LY, Kenner-Bell BM, Ricketts J, Kundu RV. Ethnic skin: kids are not just little people. Clin Dermatol 2016;34:690–7.
https://www-sciencedirect-com.ezproxy.umassmed.edu/science/article/pii/S0738081X16301808

4. Petersen RLW, Scholz CFP, Jensen A, et al. Propionibacterium acnes phylogenetic type III is associated with progressive macular hypomelanosis. Eur J Microbiol Immunol 2017;7:37–45.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5372479/

5. Pflederer RT, Wuennenberg JP, Foote C, et al. Use of woods lamp to diagnose progressive macular hypomelanosis. J Am Acad Dermatol 2017;77:e99–e100.
https://www-sciencedirect-com.ezproxy.umassmed.edu/science/article/pii/S0190962217316742

6. Relyveld GN, Kingswijk MM, Reitsma JB, et al. Benzoyl peroxide/clindamycin/uva is more effective than fluticasone/uva in progressive macular hypomelanosis: a randomized study. J Am Acad Dermatol 2006;55:836–43.
https://www.jaad.org/article/S0190-9622(06)00825-5/fulltext

7. Kim M-B, Kim G-W, Cho H-H, et al. Narrowband uvb treatment of progressive macular hypomelanosis. J Am Acad Dermatol 2012;66:598–605.
https://www.jaad.org/article/S0190-9622(11)00478-6/fulltext

8. Thng SG, Long VH, Chuah S, Tan VD. Efficacy and relapse rates of different treatment modalities for progressive macular hypomelanosis. Indian J Dermatol Venereol Leprol 2016;82:673.
http://www.ijdvl.com/article.asp?issn=0378-6323;year=2016;volume=82;issue=6;spage=673;epage=676;aulast=Thng

9. Sim J, Lee D, Lee J, Kim Y. Comparison of the clinical efficacy of nbuvb and nbuvb with benzoyl peroxide/clindamycin in progressive macular hypomelanosis. J Eur Acad Dermatol Venereol 2011;25:1318–23.
https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1468-3083.2011.03980.x
Published
2020-10-22
Info
Issue
Section
Case Reports
Keywords:
Phototherapy, pigmentary disorders, topical therapy
Statistics
  • Abstract views: 663

  • PDF: 70
How to Cite
Leonard, N., Krueger, S., & Rashighi, M. (2020). Successful treatment of progressive macular hypomelanosis. Dermatology Reports, 12(2). https://doi.org/10.4081/dr.2020.8509